14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $40.39 $44.07 Friday, 3rd May 2024 IONS stock ended at $41.97. This is 2.60% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 4.36% from a day low at $41.93 to a day high of $43.76.
90 days $40.39 $51.98
52 weeks $34.79 $54.44

Historical Ionis Pharmaceuticals prices

Date Open High Low Close Volume
Feb 22, 2024 $43.54 $44.53 $43.25 $43.98 1 299 419
Feb 21, 2024 $45.92 $46.23 $43.21 $43.53 2 073 608
Feb 20, 2024 $44.40 $45.18 $43.92 $44.35 1 886 611
Feb 16, 2024 $45.02 $45.78 $44.40 $44.43 2 087 835
Feb 15, 2024 $48.32 $49.82 $44.96 $45.28 2 811 970
Feb 14, 2024 $48.87 $49.32 $48.41 $49.07 675 119
Feb 13, 2024 $49.30 $49.55 $48.41 $48.61 1 067 002
Feb 12, 2024 $50.94 $51.87 $50.26 $50.38 823 474
Feb 09, 2024 $50.02 $51.98 $49.86 $51.40 786 998
Feb 08, 2024 $49.64 $50.32 $49.61 $49.98 597 248
Feb 07, 2024 $49.13 $49.61 $48.66 $49.54 561 689
Feb 06, 2024 $49.25 $49.68 $48.78 $49.12 1 129 291
Feb 05, 2024 $49.43 $49.65 $48.68 $49.43 732 156
Feb 02, 2024 $50.31 $50.59 $49.20 $49.75 796 595
Feb 01, 2024 $51.71 $51.71 $50.71 $50.97 596 908
Jan 31, 2024 $51.96 $52.49 $51.29 $51.39 932 984
Jan 30, 2024 $51.72 $51.98 $50.92 $51.90 917 196
Jan 29, 2024 $51.47 $52.18 $50.71 $52.01 684 121
Jan 26, 2024 $51.80 $51.93 $51.21 $51.49 943 466
Jan 25, 2024 $50.79 $51.98 $50.75 $51.58 956 169
Jan 24, 2024 $51.83 $51.83 $50.09 $50.60 1 009 195
Jan 23, 2024 $51.31 $51.81 $50.03 $51.81 925 406
Jan 22, 2024 $51.26 $51.83 $50.69 $51.01 1 419 838
Jan 19, 2024 $50.30 $51.25 $49.87 $50.98 3 070 753
Jan 18, 2024 $51.30 $51.40 $50.07 $50.65 1 059 388
Click to get the best stock tips daily for free!

About Ionis Pharmaceuticals

Ionis Pharmaceuticals Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for familial chylomicronemia syndrome and familial partial lipodystrophy. It also develops medicines for various... IONS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT